Skip to main content
[Preprint]. 2022 Nov 9:2020.08.12.246389. Originally published 2020 Aug 13. [Version 2] doi: 10.1101/2020.08.12.246389

Figure 1 – Efficacy of small molecule inhibitors against SARS-CoV-2 in Vero cells 16 hpi with inhibitor in viral inoculum.

Figure 1 –

(A.) Classification of the Small molecule inhibitors that were tested.

(B.) Drug toxicity in Vero cells at 24 hours. Cells were seeded at a density of 3E4 and overlaid with media conditioned with 0.1% DMSO or the indicated concentration of inhibitor. Cells were incubated for 24 hours at 37°C at 5% CO2. Viability was determined using CellTiter Glo assay.

(C.) Efficacy of small molecule inhibitors in Vero cells 16 hpi. Cells were seeded at a density of 3E4 and overlaid with conditioned media containing 0.1% DMSO or 5 μM of inhibitor. Cells were incubated for 2 hours. Conditioned media was removed. Viral inoculum (MOI: 0.1) containing 5 μM of inhibitor was added to cells and incubated for 1 hour at 37°C and 5% CO2. Viral inoculum was removed, cells were washed with DPBS, and conditioned media was returned to the cells. Culture was incubated for 16 hpi. Supernatants were collected and a viral plaque assay was used to quantify the viral titers.

(D.) Inhibition of SARS-CoV-2 Washington 2020 observed at 16 hpi, represented as relative percentages.

(E.) Inhibition of SARS-CoV-2 Italy 2020 observed at 16 hpi, represented as relative percentages.

The quantitative data are depicted as the mean of three biologically independent experiments ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ****p < 0.0001.